Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/03/2010CN101874761A Method for coating leucine microcapsule
11/03/2010CN101874630A Brain health-care product for improving memory and cognitive power
11/03/2010CN101632656B Preparation method of water-soluble irisolidone
11/03/2010CN101543501B Balsatazide sodium enema liquid and preparation method thereof
11/03/2010CN101456845B 4,5-diaryl-2-sulfhydryl miazines compounds and synthetic method thereof and pharmaceutical use
11/03/2010CN101444502B A high-purity tea polyphenol buccal tablets and preparation method thereof
11/03/2010CN101444492B Lomefloxacin hydrochloride lyophilized powder for injection and preparation method therefor
11/03/2010CN101371839B Novel use of bisbenzylisoquinoline alkaloids
11/03/2010CN101371838B Novel uses of neferine and analogue thereof
11/03/2010CN101361877B External washing lotion for treating gynaecologic inflammation
11/03/2010CN101361703B Sirolimos sustained and controlled release preparation and preparation method thereof
11/03/2010CN101357169B Medicine for quickly treating snake bite
11/03/2010CN101348514B Use of starfish saponin compound extracted from Culcita novaeguineae
11/03/2010CN101343274B Carbazoles alkaloid, preparation and application thereof
11/03/2010CN101342159B Application of bromine phenolic compound in preparing medicament for treating type 2 diabetes or adiposis
11/03/2010CN101338036B Biocompatible quick-gelatinizing hydrogels and method for preparing spray thereof
11/03/2010CN101328223B Fructus choerospondiatis polysaccharide and preparation process thereof
11/03/2010CN101328155B Oxazolidine derivates, preparation and application thereof
11/03/2010CN101322808B Bone fracture setting ointment
11/03/2010CN101322747B Medicament for treating mammitis
11/03/2010CN101318937B Alkaloid compounds, preparation method and application thereof
11/03/2010CN101313989B Chinese medicinal composition for treating coronary disease, stenocardia
11/03/2010CN101313948B Xianzi muscle promoting plaster
11/03/2010CN101313910B Preparation technique for sodium phosphocreatine freeze-dried injection
11/03/2010CN101302212B Preparation and use of silybum marianum di-partial succinate and salt thereof
11/03/2010CN101301365B Chinese and western compound medicament composition for treating bacterial enteritis of aquatic livestock
11/03/2010CN101297826B Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/03/2010CN101297806B Novel use of adenylate activated protein kinase inhibitor Compound C
11/03/2010CN101284103B Attapulgite delousing ointment
11/03/2010CN101279964B Guaiane type sesquiterpenes, preparation and medical use thereof
11/03/2010CN101264266B Externally-applied paste for treating gland hyperplasia
11/03/2010CN101264242B Medicaments preparations for treating hemorrhage, pain and dropsy
11/03/2010CN101252923B Adhesive skin patch
11/03/2010CN101249235B Chinese medicine for curing esophagus cancer and method of preparing the same
11/03/2010CN101235372B HBV core area resisting siRNA expression template and application
11/03/2010CN101234149B Composition for treating pain of head, face and limbs and various tendons clonic convulsion and preparation thereof
11/03/2010CN101230068B Application of polyether triterpene compound in preparing medicine for treating tumour
11/03/2010CN101230035B Aspartic acid amlodipine series salt as well as preparation method, composition, preparation and tablets thereof
11/03/2010CN101229195B Traditional Chinese medicine for treating slight burns and scalds
11/03/2010CN101203224B Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of Tie-2 kinase activity
11/03/2010CN101199509B Function of 2',2'-CH3-2'H,4H-3,6'-two benzopyran-4-ketone in preparing medicine for treating cancer
11/03/2010CN101184487B Bicyclic pyrazole compounds as antibacterial agents
11/03/2010CN101181357B Detection method of chlorphenamine Maleate of ketelin lozenge
11/03/2010CN101167871B Compound pearl lozenge and preparation method and application thereof
11/03/2010CN101143181B Traditional Chinese medicinal composition for treating senile dementia and preparation method and application thereof
11/03/2010CN101137609B Desmosdumotin, its production method and application against tumour and AIDS
11/03/2010CN101115760B Pyrrolopyrazoles, potent kinase inhibitors
11/03/2010CN101103966B Omega-3 falty acid-garlic oil capsule and manufacturing method thereof
11/03/2010CN101102744B Skin-whitening agent
11/03/2010CN101098870B Novel fused imidazole derivative
11/03/2010CN101095743B Exterior-applied medicine composition for treating gynecologic diseases and method of making the same and the use thereof
11/03/2010CN101052657B Method for production of indigestible dextrin comprising isoglucose
11/03/2010CN101043889B Use of A2b adenosine receptor antagonists in preparing medicine for promoting wound healing
11/03/2010CN101035509B Organo-gel formulations for therapeutic applications
11/03/2010CN101031288B Medium-chain length fatty alcohols as stimulators of hematopoiesis
11/03/2010CN101028043B Slow-settling swelling granular complex feed for large-yellow croaker scrod
11/02/2010USRE41911 Epothilone derivatives
11/02/2010US7825279 Fused ring dicationic anti-protozoan agents and their prodrugs
11/02/2010US7825278 Central nervous system disorders; gamma aminobutyric acid (GABA) receptor complex modulators
11/02/2010US7825271 such as 15R-5,6,15-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid; extended tissue half-life; antiinflammatory agents; anticancer agents
11/02/2010US7825268 Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
11/02/2010US7825265 di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors; 2-fluoro-1-methoxy-4-(1-phenyl-cyclohexyl)-benzene
11/02/2010US7825264 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
11/02/2010US7825263 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive
11/02/2010US7825258 such as 2-[2-(3-Chloro-benzyl)-5,6-difluoro-benzoimidazol-1-yl]-2,N-dicyclohexyl-acetamide, used for the treatment and/or prophylaxis of diseases that are affected by Farnesoid-X-receptor agonists; hyperlipemia; hypercholesterolemia
11/02/2010US7825256 Inducible nitric oxide synthase dimerization inhibitors
11/02/2010US7825255 Adenosine receptor selective modulators
11/02/2010US7825254 Heteroaromatic quinoline compounds
11/02/2010US7825251 preparing 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone (cilostazol) by reacting 6-hydroxy-3,4-dihydroquinoline-2(1H)-one and 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in an aqueous single phase
11/02/2010US7825247 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/02/2010US7825231 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
11/02/2010US7825229 MiRNAs; diagnosis, prognosis, and treatments; drug screening; linear amplification and labeling for hybridization techniques like Luminex and Microarray analysis; gene expression inhibition
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825162 administering terpenoids selected from ferruginol derivatives, dehydroabietinol, kayadiol and delta-cadinol, that inhibit acylCoenzyme A: cholesterol acyltransferases and oxidation of low-density lipoproteins, for the treatment of hyperlipemia or atherosclerosis
11/02/2010US7825161 Higher fullerenes useful as radical scavengers
11/02/2010US7825160 such as [5-(4-Fluoro-benzyloxy)-4'-trifluoromethyl-biphenyl-3-yl]-acetic acid, used for the treatment of Alzheimer's disease and for the modulation of gamma -secretase activity
11/02/2010US7825158 treating amphetamine or methamphetamine dependence by administering an effective amount of (-)1-(benzofuran-2-yl)-2-propylaminopentane, or a pharmaceutical acceptable acid salt thereof, to an amphetamine or methamphetamine-dependent patient
11/02/2010US7825157 Methods for improving the aesthetic appearance of skin
11/02/2010US7825156 Amisulpride, sultopride, sulpiride; antipsychotic drugs
11/02/2010US7825155 Oxindole derivative as feeding control agent
11/02/2010US7825154 nonpeptidic inhibitors of Botulinum neurotoxin A metalloprotease activity, such as 2-[4-(4-carbamimidoylphenoxy)phenyl]-1H-indole-5-carboximidamide, used for treating, inhibiting or preventing intoxication caused by bacteria
11/02/2010US7825153 low concentration formulation for systemic applications of photodynamic therapy of hyperproliferative tissue disease with specially enhanced pharmacokinetics and pharmacodynamics, comprising hydrophobic photosensitizer meta-tetra(hydroxyphenyl)chlorin in excipient comprising propylene glycol and ethanol
11/02/2010US7825152 Organic compounds and their uses
11/02/2010US7825151 1-cyclohexyl-4,5,6,7,8,9-hexahydro-1H-cyclooctapyrazole-3-carboxylic acid (1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amide for example; CB1 or CB2 receptor agonist, antagonist or inverse-agonists; obesity, inflammation, pain, metabolic disorders, gastrointestinal disorders, autoimmune diseases, drug abuse
11/02/2010US7825150 Compositions and methods for treating immunological and inflammatory diseases and disorders
11/02/2010US7825149 such as 2-[1-(2-chloro-3-methylphenyl)ethyl]-1H-imidazole, used for the treatment of parasitic infection in plants or animals ; parasiticides
11/02/2010US7825148 heat shock protein 90 inhibitors such as 3-(2-Hydroxyphenyl)-4-(naphthalen-1-yl)-5-mercapto-triazole, used for for preventing or treating hyperproliferative disorders, such as cancer
11/02/2010US7825147 Enzyme inhibitors of phosphodiesterases for treatment of AIDS, asthma, arthritis, bronchitis and other disorders
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825145 Antimicrobial and radioprotective compounds
11/02/2010US7825144 chemical intermediates such as 2-(3-Methoxyphenyl)-4,5-dimethyloxazole 3-oxide, capable of being transformed to halomethyloxazoles smoothly with high yield and great purity
11/02/2010US7825143 contacting a fungal cell with an anti-fungal small molecule in an amount effective to reduce or inhibit the yeast-to-filamentous growth transition, wherein the anti-fungal small molecule is 5-(p-bromobenzylidine)- alpha -isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid
11/02/2010US7825142 imidazole-based compounds such as (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol, used for the treatment and prevention of inflammatory and autoimmune diseases
11/02/2010US7825141 Epothilone derivatives
11/02/2010US7825140 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
11/02/2010US7825139 Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
11/02/2010US7825138 Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
11/02/2010US7825137 Method of treating abnormal cell growth
11/02/2010US7825136 mixture of antibiotics, carriers and activators such as (S)-1-((3,4,5-Trimethoxyphenyl)-methyl-carbamoyl)-piperidine-2-carboxylic acid 4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)-butyl ester, used for treatment of bacterial infection in mammals